Press Release Annexon Appoints Renowned Retinal Surgeon and Biotechnology Entrepreneur Mark S. Blumenkranz, M.D., M.M.S. to its Board of Directors 3 hours ago
Press Release Annexon Reports First U.S. and European Patient Cohort of GBS FORWARD Study Demonstrated Rapid, Positive Clinical Responses in All Tanruprubart Treated Patients Within One Week Aug 6
Press Release Annexon Secures Strategic Credit Facility for up to $200 Million from Oxford Finance Jul 30